ArticleScientific reports2025
Machine learning model and hemoglobin to red cell distribution width ratio evaluates all-cause mortality in pulmonary embolism.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Associations of Red Blood Cell Distribution Width-Derived Indicators and Their Longitudinal Dynamic Trajectories With Mortality Risk in Critically Ill Patients With Pulmonary Hypertension.Pulmonary circulation · 2026Article
- [Correlation between cardiovascular health score based on eight life factors and prognosis of ischemic stroke and mediating effect of clinical test indicators: a multicenter prospective cohort study].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026Observational
- Predictive value of hemoglobin-to-red cell distribution width ratio for mortality in new-onset atrial fibrillation after cardiac surgery a machine learning study based on the MIMIC-IV database.BMC cardiovascular disorders · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ratio of hemoglobin (Hb) to red blood cell distribution width (RDW), known as HRR, functions as an innovative indicator related to prognosis. However, whether HRR can predict the mortality for pulmonary embolism (PE) patients remains ambiguous. A retrospective cohort study was conducted using the MIMIC IV database (3.0), All patients were categorized into four groups based on the HRR. We investigated the association between HRR and PE mortality. Cox regression models were used to evaluate these associations, while restricted cubic spline (RCS) regressions assessed potential nonlinear relationships. In addition, six machine learning models, including random survival forest (RSF), conditional Inference Tree(ctree), gradient boosting machine (gbm), nearest neighbors (nn), and extreme gradient boosting (xgboost), were applied, with Shapley additive explanation (SHAP) are used to determine the importance of characteristics. 2,272 PE patients were eligible for analysis. Our study identified both age and HRR levels (both with OR > 1, P < 0.05) as significant predictors of 30-day and 365-day mortality in PE patients admitted to the ICU. In Cox regression analysis, both age and HRR (both with HR > 1, P < 0.05) also emerged as prognostic risk factors for 30-day and 365-day mortality in this patient population. KM analysis demonstrated that patients with PE who were older or had increased HRR levels while hospitalized or in the ICU exhibited considerably reduced survival rates in comparison to younger individuals or those with lower HRR levels (P < 0.0001). Additionally, the RCS analysis revealed a pronounced nonlinear association between HRR levels and the risk of mortality. Validation set, coxph (ROC: 0.772) demonstrated superior predictive accuracy for these endpoints. identifying HRR as a vital component of mortality. A lower HRR correlates with high mortality rate in patients with PE patients. This model could serve as a useful tool for guiding mortality, assisting in clinical decision-making and improving patient management outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.